Last updated: April 25, 2026
Who Supplies Kimyrsa (romosozumab-aqqg)?
Kimyrsa is a brand of romosozumab-aqqg, a monoclonal antibody for osteoporosis. In practice, “suppliers” for a drug like Kimyrsa break into two buckets: manufacturing sites under the drug’s labeled supply chain and wholesaler/distribution partners used to move inventory through the U.S. channel.
The available record does not include a complete, citable list of Kimyrsa-specific manufacturers/suppliers (for API, fill-finish, or labeled primary packager), nor a citable list of the specific U.S. distribution wholesalers tied to Kimyrsa.
What Supplier Data Can Be Determined From Public Records?
Which suppliers appear in Kimyrsa’s distribution channel?
A complete, verifiable supplier roster is not available in the provided inputs. No Kimyrsa-specific wholesaler list is supplied here.
Which manufacturers appear for Kimyrsa production?
A complete, verifiable list of Kimyrsa manufacturing suppliers (API manufacturer, drug substance manufacturer, fill-finish manufacturer, and labeler) is not available in the provided inputs.
Operational Implications for Sourcing and Commercialization
How “supplier” typically maps to Kimyrsa’s procurement
For a monoclonal antibody like romosozumab-aqqg, procurement teams usually separate sources into:
- Drug substance (API) manufacturing
- Drug product (fill-finish) manufacturing
- Packaging and labeling
- Distribution and logistics partners
Without Kimyrsa-labeled manufacturing and distribution identifiers, procurement cannot be tied to named suppliers or sites.
Kimyrsa Technical Anchor Points (for supplier qualification)
These points define what procurement should benchmark once supplier sites are identified from labeled/filing records:
| Attribute |
Kimyrsa / romosozumab-aqqg |
| Drug class |
Monoclonal antibody (sclerostin inhibitor) |
| Indication (high level) |
Osteoporosis treatment (per U.S. prescribing information) |
| Supplier qualification focus |
mAb manufacturing controls, biologics fill-finish GMP, cold-chain handling |
(These anchor points guide qualification, but they do not provide named suppliers.)
Key Takeaways
- Kimyrsa supplier identification requires named manufacturing and distribution partners tied to the labeled supply chain.
- The provided information does not include the citable supplier roster needed to list specific Kimyrsa suppliers.
FAQs
-
Who manufactures the API for Kimyrsa?
Not provided in the available material.
-
Who performs fill-finish for Kimyrsa?
Not provided in the available material.
-
Which wholesalers distribute Kimyrsa in the U.S.?
Not provided in the available material.
-
Does Kimyrsa have multiple manufacturing sites?
Not provided in the available material.
-
What supplier documents are typically required to validate a Kimyrsa sourcing partner?
Manufacturing site GMP evidence and cold-chain logistics documentation, tied to the specific product label and lot traceability.
References
[1] FDA. Kimyrsa (romosozumab-aqqg) prescribing information (accessed via FDA drug label repository).
